A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C

Although interferon alfa (IFN-α) and ribavirin are widely used in the treatment of hepatitis C, their role in the transplant recipient is unclear. We conducted a pilot study to determine the efficacy and safety of this therapy in transplant recipients with recurrent hepatitis C. Patients at least 6...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2002-11, Vol.36 (5), p.1253-1258
Hauptverfasser:	Shakil, A.Obaid, McGuire, Brendon, Crippin, Jeff, Teperman, Lewis, Demetris, A.Jake, Conjeevaram, Hari, Gish, Robert, Kwo, Paul, Balan, Vijayan, Wright, Teresa L., Brass, Clifford, Rakela, Jorge
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Biological and medical sciences Drug Therapy, Combination Female Follow-Up Studies Hepatitis C - drug therapy Human viral diseases Humans Infectious diseases Interferon-alpha - administration & dosage Interferon-alpha - adverse effects Liver Transplantation Male Medical sciences Middle Aged Patient Dropouts Pilot Projects Postoperative Complications - drug therapy Postoperative Complications - virology Recurrence Ribavirin - administration & dosage Ribavirin - adverse effects Treatment Outcome Viral diseases Viral hepatitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!